# National Presto Industries Inc: financial statements, quarterly

NPK · NYSE · CIK 80172 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/npk.md) · [Financials](/companies/npk/financials.md) · [Filings](/companies/npk/filings.md) · [Insiders](/companies/npk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/npk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [83.1](/filings/0001437749-25-007735.md) | [98.4](/filings/0001437749-25-007735.md) | [76.7](/filings/0001437749-26-008214.md) | [85.1](/filings/0001437749-26-008214.md) | [91.8](/filings/0001437749-26-008214.md) | [135](/filings/0001437749-26-008214.md) | [104](/filings/0001437749-26-017365.md) | [120](/filings/0001437749-26-027999.md) | [115](/filings/0001437749-26-008214.md) | [164](/filings/0001437749-26-008214.md) | [119](/filings/0001437749-26-017365.md) | [147](/filings/0001437749-26-027999.md) |
| Cost of revenue | $m | [67.7](/filings/0001437749-24-034199.md) | [77.8 d](/filings/0001437749-26-008214.md) | [62.8](/filings/0001437749-25-015772.md) | [70.4](/filings/0001437749-25-025717.md) | [74.6](/filings/0001437749-25-033854.md) | [102 d](/filings/0001437749-26-008214.md) | [85.5](/filings/0001437749-26-017365.md) | [102](/filings/0001437749-26-027999.md) | [99.5](/filings/0001437749-25-033854.md) | [136 d](/filings/0001437749-26-008214.md) | [101](/filings/0001437749-26-017365.md) | [118](/filings/0001437749-26-027999.md) |
| Gross profit | $m | [15.4](/filings/0001437749-25-007735.md) | [20.7](/filings/0001437749-25-007735.md) | [13.9](/filings/0001437749-26-008214.md) | [14.7](/filings/0001437749-26-008214.md) | [17.2](/filings/0001437749-26-008214.md) | [32.8](/filings/0001437749-26-008214.md) | [18.1](/filings/0001437749-26-017365.md) | [18.5](/filings/0001437749-26-027999.md) | [16.0](/filings/0001437749-26-008214.md) | [27.7](/filings/0001437749-26-008214.md) | [17.5](/filings/0001437749-26-017365.md) | [28.5](/filings/0001437749-26-027999.md) |
| Selling, general and administrative | $m | [7.9](/filings/0001437749-24-034199.md) | [7.0 d](/filings/0001437749-26-008214.md) | [7.2](/filings/0001437749-25-015772.md) | [8.0](/filings/0001437749-25-025717.md) | [7.6](/filings/0001437749-25-033854.md) | [9.1 d](/filings/0001437749-26-008214.md) | [8.7](/filings/0001437749-26-017365.md) | [9.4](/filings/0001437749-26-027999.md) | [9.2](/filings/0001437749-25-033854.md) | [8.6 d](/filings/0001437749-26-008214.md) | [10.7](/filings/0001437749-26-017365.md) | [8.7](/filings/0001437749-26-027999.md) |
| Operating income | $m | [7.1](/filings/0001437749-24-034199.md) | [13.3 d](/filings/0001437749-26-008214.md) | [6.3](/filings/0001437749-25-015772.md) | [6.4](/filings/0001437749-25-025717.md) | [9.2](/filings/0001437749-25-033854.md) | [23.4 d](/filings/0001437749-26-008214.md) | [9.1](/filings/0001437749-26-017365.md) | [6.1](/filings/0001437749-26-027999.md) | [6.4](/filings/0001437749-25-033854.md) | [18.7 d](/filings/0001437749-26-008214.md) | [8.0](/filings/0001437749-26-017365.md) | [19.4](/filings/0001437749-26-027999.md) |
| Income tax | $m | [1.8](/filings/0001437749-24-034199.md) | [2.0 d](/filings/0001437749-26-008214.md) | [1.8](/filings/0001437749-25-015772.md) | [1.8](/filings/0001437749-25-025717.md) | [2.3](/filings/0001437749-25-033854.md) | [3.4 d](/filings/0001437749-26-008214.md) | [2.2](/filings/0001437749-26-017365.md) | [1.5](/filings/0001437749-26-027999.md) | [1.5](/filings/0001437749-25-033854.md) | [3.8 d](/filings/0001437749-26-008214.md) | [2.0](/filings/0001437749-26-017365.md) | [4.4](/filings/0001437749-26-027999.md) |
| Net income | $m | [7.0](/filings/0001437749-25-007735.md) | [13.2](/filings/0001437749-25-007735.md) | [6.6](/filings/0001437749-26-008214.md) | [6.1](/filings/0001437749-26-008214.md) | [8.1](/filings/0001437749-26-008214.md) | [20.7](/filings/0001437749-26-008214.md) | [7.6](/filings/0001437749-26-017365.md) | [5.2](/filings/0001437749-26-027999.md) | [5.3](/filings/0001437749-26-008214.md) | [15.0](/filings/0001437749-26-008214.md) | [6.6](/filings/0001437749-26-017365.md) | [15.9](/filings/0001437749-26-027999.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.99](/filings/0001437749-25-007735.md) | [1.85](/filings/0001437749-25-007735.md) | [0.92](/filings/0001437749-26-008214.md) | [0.85](/filings/0001437749-26-008214.md) | [1.13](/filings/0001437749-26-008214.md) | [2.92](/filings/0001437749-26-008214.md) | [1.07](/filings/0001437749-26-017365.md) | [0.72](/filings/0001437749-26-027999.md) | [0.74](/filings/0001437749-26-008214.md) | [2.10](/filings/0001437749-26-008214.md) | [0.93](/filings/0001437749-26-017365.md) | [2.21](/filings/0001437749-26-027999.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [70.4](/filings/0001437749-23-031605.md) | [87.7](/filings/0001437749-25-007735.md) | [63.5](/filings/0001437749-24-016001.md) | [32.6](/filings/0001437749-24-025857.md) | [16.3](/filings/0001437749-24-034199.md) | [17.7](/filings/0001437749-26-008214.md) | [1.0](/filings/0001437749-25-015772.md) | [1.8](/filings/0001437749-25-025717.md) | [2.1](/filings/0001437749-25-033854.md) | [3.3](/filings/0001437749-26-027999.md) | [6.5](/filings/0001437749-26-017365.md) | [15.8](/filings/0001437749-26-027999.md) |
| Current assets | $m | [334](/filings/0001437749-23-031605.md) | [360](/filings/0001437749-25-007735.md) | [338](/filings/0001437749-24-016001.md) | [340](/filings/0001437749-24-025857.md) | [349](/filings/0001437749-24-034199.md) | [367](/filings/0001437749-26-008214.md) | [347](/filings/0001437749-25-015772.md) | [365](/filings/0001437749-25-025717.md) | [398](/filings/0001437749-25-033854.md) | [403](/filings/0001437749-26-027999.md) | [374](/filings/0001437749-26-017365.md) | [402](/filings/0001437749-26-027999.md) |
| Total assets | $m | [416](/filings/0001437749-24-034199.md) | [441](/filings/0001437749-25-007735.md) | [417](/filings/0001437749-24-016001.md) | [418](/filings/0001437749-24-025857.md) | [429](/filings/0001437749-24-034199.md) | [453](/filings/0001437749-26-008214.md) | [455](/filings/0001437749-25-015772.md) | [472](/filings/0001437749-25-025717.md) | [504](/filings/0001437749-25-033854.md) | [501](/filings/0001437749-26-027999.md) | [469](/filings/0001437749-26-017365.md) | [499](/filings/0001437749-26-027999.md) |
| Current liabilities | $m | [63.4](/filings/0001437749-23-031605.md) | [72.0](/filings/0001437749-25-007735.md) | [73.7](/filings/0001437749-24-016001.md) | [68.0](/filings/0001437749-24-025857.md) | [70.5](/filings/0001437749-24-034199.md) | [74.4](/filings/0001437749-26-008214.md) | [75.5](/filings/0001437749-25-015772.md) | [86.7](/filings/0001437749-25-025717.md) | [113](/filings/0001437749-25-033854.md) | [95.0](/filings/0001437749-26-027999.md) | [63.6](/filings/0001437749-26-017365.md) | [76.9](/filings/0001437749-26-027999.md) |
| Total liabilities | $m | [73.3](/filings/0001437749-23-031605.md) | [84.3](/filings/0001437749-25-007735.md) | [85.8](/filings/0001437749-24-016001.md) | [80.0](/filings/0001437749-24-025857.md) | [82.3](/filings/0001437749-24-034199.md) | [85.8](/filings/0001437749-26-008214.md) | [86.7](/filings/0001437749-25-015772.md) | [97.8](/filings/0001437749-25-025717.md) | [124](/filings/0001437749-25-033854.md) | [106](/filings/0001437749-26-027999.md) | [74.1](/filings/0001437749-26-017365.md) | [87.3](/filings/0001437749-26-027999.md) |
| Shareholders' equity | $m | [343](/filings/0001437749-24-034199.md) | [356](/filings/0001437749-26-008214.md) | [332](/filings/0001437749-25-025717.md) | [338](/filings/0001437749-25-033854.md) | [347](/filings/0001437749-25-033854.md) | [368](/filings/0001437749-26-027999.md) | [369](/filings/0001437749-26-027999.md) | [374](/filings/0001437749-26-027999.md) | [380](/filings/0001437749-25-033854.md) | [395](/filings/0001437749-26-027999.md) | [395](/filings/0001437749-26-017365.md) | [411](/filings/0001437749-26-027999.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.2) d](/filings/0001437749-24-034199.md) | [16.6 d](/filings/0001437749-26-008214.md) | [5.6](/filings/0001437749-25-015772.md) | [(33.9) d](/filings/0001437749-25-025717.md) | [(17.5) d](/filings/0001437749-25-033854.md) | [(7.6) d](/filings/0001437749-26-008214.md) | [12.5](/filings/0001437749-26-017365.md) | [(10.9) d](/filings/0001437749-26-027999.md) | [(24.6) d](/filings/0001437749-25-033854.md) | [13.9 d](/filings/0001437749-26-008214.md) | [31.3](/filings/0001437749-26-017365.md) | [12.8 d](/filings/0001437749-26-027999.md) |
| Capital expenditure | $m | [0.9](/filings/0001437749-24-034199.md) | [0.1 d](/filings/0001437749-26-008214.md) | [0.4](/filings/0001437749-25-015772.md) | [0.8](/filings/0001437749-24-025857.md) | [2.8](/filings/0001437749-24-034199.md) | [3.7 d](/filings/0001437749-26-008214.md) | [23.0](/filings/0001437749-26-017365.md) | [2.5 d](/filings/0001437749-26-027999.md) | [0.1 d](/filings/0001437749-25-033854.md) | [1.5 d](/filings/0001437749-26-008214.md) | [2.0](/filings/0001437749-26-017365.md) | [3.5 d](/filings/0001437749-26-027999.md) |
| Dividends paid | $m | [0.0 d](/filings/0001437749-24-034199.md) | [0.0 d](/filings/0001437749-26-008214.md) | [32.0](/filings/0001437749-25-015772.md) | [0.0 d](/filings/0001437749-25-025717.md) | [0.0 d](/filings/0001437749-25-033854.md) | [0.0 d](/filings/0001437749-26-008214.md) | [7.1](/filings/0001437749-26-017365.md) | [0.0 d](/filings/0001437749-26-027999.md) | [0.0 d](/filings/0001437749-25-033854.md) | [0.0 d](/filings/0001437749-26-008214.md) | [7.2](/filings/0001437749-26-017365.md) | [0.0 d](/filings/0001437749-26-027999.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2010-07-04) | period not labelled (2010-10-03) | period not labelled (2011-04-03) | Q2 FY2011 (2011-07-03) | Q3 FY2011 (2011-10-02) | Q1 FY2012 (2012-04-01) | Q2 FY2012 (2012-07-01) | Q3 FY2012 (2012-09-30) | Q1 FY2013 (2013-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,863](/filings/0000897101-11-001421.md) | [6,865](/filings/0000897101-11-001957.md) | [6,867](/filings/0000897101-12-000767.md) | [6,872](/filings/0000897101-12-001355.md) | [6,876](/filings/0000897101-12-001926.md) | [6,885](/filings/0000897101-13-000716.md) | [6,884](/filings/0000897101-12-001355.md) | [6,893](/filings/0000897101-12-001926.md) | [6,906](/filings/0000897101-13-000716.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,136,067 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-027999.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.